Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Inmune Bio Inc (INMB)

Inmune Bio Inc (INMB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 335,429
  • Shares Outstanding, K 17,842
  • Annual Sales, $ 10 K
  • Annual Income, $ -12,100 K
  • 60-Month Beta 2.84
  • Price/Sales 29,601.50
  • Price/Cash Flow N/A
  • Price/Book 6.69
Trade INMB with:

Options Overview Details

View History
  • Implied Volatility 95.23%
  • Historical Volatility 61.73%
  • IV Percentile 4%
  • IV Rank 35.47%
  • IV High 159.55% on 08/18/21
  • IV Low 59.88% on 03/19/21
  • Put/Call Vol Ratio 0.20
  • Today's Volume 234
  • Volume Avg (30-Day) 290
  • Put/Call OI Ratio 0.19
  • Today's Open Interest 1,108
  • Open Int (30-Day) 1,385

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.43
  • Number of Estimates 2
  • High Estimate -0.42
  • Low Estimate -0.43
  • Prior Year -0.36
  • Growth Rate Est. (year over year) -19.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.83 +13.78%
on 10/08/21
21.70 -11.75%
on 09/27/21
+0.54 (+2.90%)
since 09/21/21
3-Month
13.06 +46.63%
on 08/05/21
30.37 -36.94%
on 09/07/21
-3.58 (-15.75%)
since 07/21/21
52-Week
7.28 +163.05%
on 10/30/20
30.37 -36.94%
on 09/07/21
+11.17 (+139.97%)
since 10/21/20

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

INmune Bio Inc. is a clinical-stage biotechnology company. It engages in developing therapies targeting the innate immune system in cancer. The company's product platform consists of INKmune and INB03. INKmune is a natural killer cell therapeutic which primes the patient's NK cells to attack developing...

See More

Key Turning Points

3rd Resistance Point 20.29
2nd Resistance Point 19.55
1st Resistance Point 19.17
Last Price 18.91
1st Support Level 18.05
2nd Support Level 17.31
3rd Support Level 16.93

See More

52-Week High 30.37
Fibonacci 61.8% 21.55
Last Price 18.91
Fibonacci 50% 18.83
Fibonacci 38.2% 16.10
52-Week Low 7.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar